O. Damm, Marc Nocon, S. Roll, C. Vauth, S. Willich, W. Greiner
{"title":"Impfung gegen humane Papillomaviren (HPV) zur Prävention HPV 16/18 induzierter Zervixkarzinome und derer Vorstufen","authors":"O. Damm, Marc Nocon, S. Roll, C. Vauth, S. Willich, W. Greiner","doi":"10.15488/514","DOIUrl":null,"url":null,"abstract":"Essential precondition for the development of cervical cancer is a persistent human papillomavirus (HPV) infection. The majority approximOliver Damm Marc Nocon Stephanie Roll Christoph Vauth ately 70% of cervical carcinomas is caused by two high-risk HPV types (16 and 18). Recently, two vaccines have been approved to the German Stefan Willich market with the potential to induce protection against HPV 16 and HPV 18 among additional low-risk virus types. Wolfgang Greiner 1","PeriodicalId":89142,"journal":{"name":"GMS health technology assessment","volume":"5 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"GMS health technology assessment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15488/514","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4
Abstract
Essential precondition for the development of cervical cancer is a persistent human papillomavirus (HPV) infection. The majority approximOliver Damm Marc Nocon Stephanie Roll Christoph Vauth ately 70% of cervical carcinomas is caused by two high-risk HPV types (16 and 18). Recently, two vaccines have been approved to the German Stefan Willich market with the potential to induce protection against HPV 16 and HPV 18 among additional low-risk virus types. Wolfgang Greiner 1
宫颈癌发展的基本前提是持续的人乳头瘤病毒(HPV)感染。大多数近似oliver Damm Marc Nocon Stephanie Roll Christoph Vauth估计70%的宫颈癌是由两种高危型HPV(16和18)引起的。最近，两种疫苗已被批准进入德国Stefan Willich市场，有可能在其他低风险病毒类型中诱导对HPV 16和HPV 18的保护。沃尔夫冈·格雷纳1
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
